Navigation Links
Baxter to Launch GARDian(TM), a Groundbreaking Initiative That Helps Provide Continued Access to GAMMAGARD for Current Patients
Date:8/22/2007

ary enrollment process administered through patients' healthcare providers, enrollees will have the comfort that GAMMAGARD LIQUID and GAMMAGARD S/D is available to them even if they experience changes involving their providers or site of care. A third party vendor will manage the program, and Baxter will not have access to patient data.

Enrollment in this program will be voluntary and will not automatically preclude those patients not participating in the program from accessing GAMMAGARD LIQUID and GAMMAGARD S/D. Baxter will continue to work closely with patient organizations and key thought leaders from different clinical specialties that prescribe IGIV therapy to launch the program. Patients not enrolling in the voluntary GARDian program will still be eligible for other GAMMAGARD patient programs (e.g. GAMMAssist and the Low IgA/Brand Intolerance Program and product Portability programs).

"Baxter has a long, proud history of advancing the science of IGIV therapy and serving the patients who rely on our IGIV therapies," said Larry Guiheen, president, Baxter Biopharmaceuticals, North America. "Baxter is committed to providing continued access to their therapy of choice for our patients. The GARDian program represents our continued commitment to that goal."

Patients and physicians can sign up to receive more information about the GARDian program at http://www.immunedisease.com.

About GAMMAGARD LIQUID 10%

GAMMAGARD LIQUID is indicated for the treatment of primary immunodeficiency disorders associated with defects in humoral immunity. These include but are not limited to congenital X-linked agammaglobulinemia, common variable immunodeficiency, Wiskott-Aldrich syndrome, and severe combined immunodeficiencies.

About GAMMAGARD S/D

GAMMAGARD S/D is indicated for the treatment of primary immunodeficiency disorders associated with defects in humoral immunity. These include but
'/>"/>

SOURCE Baxter International Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Merge launches diagnostic mammography workstation in Europe
2. Einstein Wireless launches cellular alert system
3. Logistics Health launches compliance management tool
4. UW-Madison launches new high-speed research network
5. UWM launches research foundation
6. Weather information companies launch data product
7. TeraMedica launches information manager
8. GE Healthcare launches hybrid electronic record
9. Cedara launches new version of DICOM toolkit
10. Merge launches Spanish version of imaging tool
11. Orbitec will use $25 million Air Force contract to make small launch vehicle
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... May 24, 2013 Quincy Bioscience, ... and development of calcium-binding proteins to support healthy ... safety assessment study of apoaequorin in ... published for the British Industrial Biological Research Association. ... to investigate potential adverse effects, if any, of ...
(Date:5/23/2013)... Can economic incentives such as gift cards, T-shirts, ... public to increase their donations of blood? , A ... School Assistant Professor Mario Macis says the answer ... of recent research that supports their argument, the three ... Science that the World Health Organization and national blood ...
(Date:5/23/2013)... The maker community is a contemporary ... They focus on learning practical skills while applying them ... bringing their ideas to life via crowdfunding. A subgroup ... making projects using biology. Glowing Plant has worked for ... them glow with bioluminescence genes, and has now pursued ...
(Date:5/23/2013)... BioTrends Research Group, one of the ... biopharmaceutical issues, finds that, unaided, one in five ... that in the past six months, they have ... anticipation of the next generation of HCV treatments—notably ... 6 percent reported that they had begun warehousing ...
Breaking Biology Technology:Safety Assessment Study of Apoaequorin Published in Food and Chemical Toxicology 2Offering Economic Incentives to Attract Blood Donations Should Be Encouraged, Research Team writes in Science 2Offering Economic Incentives to Attract Blood Donations Should Be Encouraged, Research Team writes in Science 3Glowing Plant Releases Maker Kit, Enabling Anyone to Make a Glowing Plant at Home 2The Majority of Physicians that Treat Hepatitis C Virus (HCV) Have Begun "Warehousing" and Preparing Their HCV Patients for the Next Generation of HCV Treatments 2The Majority of Physicians that Treat Hepatitis C Virus (HCV) Have Begun "Warehousing" and Preparing Their HCV Patients for the Next Generation of HCV Treatments 3
... Heritage Labs, a,division of Hooper Holmes (Amex: ... a new at-home consumer product that measures the ... The Appraise(R) Home,A1c Kit provides consumers with an ... and reliable test results equivalent to whole,blood tests ...
... YORK, Aug. 7 Keryx Biopharmaceuticals,Inc. (Nasdaq: KERX ... 11, 2008,at 8:30 a.m. EDT to discuss the second ... Executive Officer of the Company, will,host the call. Keryx ... press release to be issued prior to the call., ...
... (OTC Bulletin Board: GNTA) today announced financial results,for the ... in the second quarter, including the following:, -- ... -- AGENDA Phase 3 trial of Genasense in ... tesetaxel, a leading, clinical-stage oral taxane,lifted by FDA, ...
Cached Biology Technology:Hooper Holmes' Heritage Labs Division Launches New Home Diabetes Test 2Hooper Holmes' Heritage Labs Division Launches New Home Diabetes Test 3Hooper Holmes' Heritage Labs Division Launches New Home Diabetes Test 4Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Second Quarter 2008 Financial Results on Monday, August 11, at 8:30 A.M. EDT 2Genta Incorporated Announces Second Quarter 2008 Financial Results and Corporate Highlights 2Genta Incorporated Announces Second Quarter 2008 Financial Results and Corporate Highlights 3Genta Incorporated Announces Second Quarter 2008 Financial Results and Corporate Highlights 4Genta Incorporated Announces Second Quarter 2008 Financial Results and Corporate Highlights 5Genta Incorporated Announces Second Quarter 2008 Financial Results and Corporate Highlights 6Genta Incorporated Announces Second Quarter 2008 Financial Results and Corporate Highlights 7Genta Incorporated Announces Second Quarter 2008 Financial Results and Corporate Highlights 8Genta Incorporated Announces Second Quarter 2008 Financial Results and Corporate Highlights 9Genta Incorporated Announces Second Quarter 2008 Financial Results and Corporate Highlights 10
(Date:5/23/2013)... mechanism by which estrogen suppresses lipid synthesis in the ... approach toward treating certain liver diseases. , With ... are changing long-held views in the field. Study results ... Science Signaling . , "The dogma in the ... only receptors located in the nucleus respond to steroid ...
(Date:5/23/2013)... Given the implications for the overall health, development, ... a primary role in ensuring that all students ... minutes per day of vigorous or moderate-intensity physical ... of Medicine. Recent estimates suggest that only ... guideline for promoting better health and development. ...
(Date:5/23/2013)... 2013) A new report from the Institute of ... engage in at least 60 minutes of vigorous or ... more than half of American youth meet current evidence-based ... moderate intensity physical activity daily, according to the report, ... in school for nearly half of their waking hours, ...
Breaking Biology News(10 mins):UCI study reveals new mechanism for estrogen suppression of liver lipid synthesis 2Schools should provide opportunities for 60 minutes of daily physical activity to all students 2Schools should provide opportunities for 60 minutes of daily physical activity to all students 3Schools should provide students with daily physical activity, IOM recommends 2
... 5, 2007) As if being admitted to the ... higher risk of becoming infected with a superbug bacterium, ... difficile kill human intestinal cells by causing them to ... fuel. This results in severe diarrhea and, in rare ...
... dog-walking in bushland significantly reduces bird diversity and ... practice in sensitive bushland and conservation areas. ... impacts of dog-walking have remained subjective and unresolved ... the first clear evidence that birds perceive dogs ...
... know. The supermarket headlines tell us so., Inquiring Texas ... B a tiny, sometimes obscure pest that can damage ... to young cotton for about four weeks," said Dr. ... Lubbock. "They feed on new plant growth, primarily the ...
Cached Biology News:Curbing C. difficile's toxin production 2A dog in the hand scares birds in the bush 2Inquiring minds want to know about cotton fleahoppers 2Inquiring minds want to know about cotton fleahoppers 3
Recombinant Equine TNF-alpha/TNFSF1A, CF...
GRADIENT MAKER, 30 ML, 1 EA. Category: Protein Vertical Instruments....
DALT GRADIENT MAKER,230V, 1 EA. Category: 2D DALT Systems....
Rat whole blood (Sprague-Dawley, averaging 7-8 weeks of age, either sex) is collected at the time of slaughter and refrigerated within 6 hours, and processed and frozen within 24 hours. The serum is ...
Biology Products: